It’s the hardest calculation any investor can make , how to valve a company that does not make a profit but has a new product that is required . It’s something that we seem to come across more frequently these days with new tech and medical advancements . The answer can only at best be an estimate without the required factual figures and reliance on information provided to the market via the company . The latest quarterly statement will provide some information and I’m sure we would all calculate and estimate a different figure .
Please do your own research , as the above is only in my opinion and is certainly not to be used as advice .
Ann: Becoming a substantial holder, page-253
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
-0.001(2.08%) |
Mkt cap ! $22.32M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.7¢ | 4.2¢ | $19.38K | 424.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 231096 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 142144 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| NOR (ASX) Chart |